Skip to main content
. 2022 Feb 10;52(3):173–197. doi: 10.4070/kcj.2021.0401

Table 7. Potential pitfalls of gene therapy for heart failure.

Detail
1. Inadequate gene transfer to the target cell – issues related to dose, vector, mode of delivery
2. Elimination by the immune system – need for immunosuppression in some cases
3. Liver sequestration
4. Off-target effects
5. Episomal degradation – long term gene expression desirable in heart failure patients
6. Limited scale up capacity of gene therapy medicinal products